This study aims to explore the impact of the BDNF Val66Met polymorphism on cognitive function in patients with SIVD and its possible association with imaging markers of small vessel disease and blood biomarkers for AD pathology, neuroinflammation, and neurodegeneration. Here, BDNF is linked to Alzheimer disease.